The potential role of regulator of G-protein signaling 16 in cell motility mediated by δeF1 family proteins

FEBS Letters

Volumn 590, Issue 2, 2016, Pages 270-278

  Hoshi, Yuta ^a   Endo, Kaori ^a   Shirakihara, Takuya ^b   Fukagawa, Akihiko ^a   Miyazawa, Keiji ^a   Saitoh, Masao ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

epithelial mesenchymal transition; regulator of G protein signaling 16; smad interacting protein 1; EF1; EF1 family proteins

Indexed keywords

DELTA EF1 FAMILY PROTEIN; PEPTIDES AND PROTEINS; PROTEIN RGS16; PROTEIN SIP1; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; HOMEODOMAIN PROTEIN; REPRESSOR PROTEIN; RGS PROTEIN; RGS16 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ZEB1; ZEB1 PROTEIN, HUMAN; ZEB2 PROTEIN, HUMAN;

ARTICLE; BASAL LIKE BREAST CANCER; BREAST CANCER; BREAST CANCER CELL LINE; CELL MOTILITY; CONTROLLED STUDY; GAIN OF FUNCTION MUTATION; HUMAN; HUMAN CELL; LOSS OF FUNCTION MUTATION; LUMINAL BREAST CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; BREAST TUMOR; CELL MOTION; EPITHELIAL MESENCHYMAL TRANSITION; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; EPITHELIAL-MESENCHYMAL TRANSITION; HOMEODOMAIN PROTEINS; HUMANS; REPRESSOR PROTEINS; RGS PROTEINS; TRANSCRIPTION FACTORS; ZINC FINGER E-BOX-BINDING HOMEOBOX 1;

EID: 84957310749     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1002/1873-3468.12042     Document Type: Article

References (16)

1. Bansal G, Druey KM, and, Xie Z, (2007) R4 RGS proteins: regulation of G-protein signaling and beyond. Pharmacol Ther 116, 473-495.
2. Liang G, Bansal G, Xie Z, and, Druey KM, (2009) RGS16 inhibits breast cancer cell growth by mitigating phosphatidylinositol 3-kinase signaling. J Biol Chem 284, 21719-21727.
3. Wiechec E, Overgaard J, and, Hansen LL, (2008) A fragile site within the HPC1 region at 1q25.3 affecting RGS16, RGSL1, and RGSL2 in human breast carcinomas. Genes Chromosom Cancer 47, 766-780.
4. Kim JH, Lee JY, Lee KT, Lee JK, Lee KH, Jang KT, Heo JS, Choi SH, and, Rhee JC, (2010) RGS16 and FosB underexpressed in pancreatic cancer with lymph node metastasis promote tumor progression. Tumour Biol 31, 541-548.
5. Thiery JP, Acloque H, Huang RY, and, Nieto MA, (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139, 871-890.
6. Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T, Clark L, Bayani N, Coppe JP, Tong F, et al,. (2006) A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10, 515-527.
7. Charafe-Jauffret E, Ginestier C, Monville F, Finetti P, Adelaide J, Cervera N, Fekairi S, Xerri L, Jacquemier J, Birnbaum D, et al,. (2006) Gene expression profiling of breast cell lines identifies potential new basal markers. Oncogene 25, 2273-2284.
8. Horiguchi K, Sakamoto K, Koinuma D, Semba K, Inoue A, Inoue S, Fujii H, Yamaguchi A, Miyazawa K, Miyazono K, et al,. (2012) TGF-β drives epithelial-mesenchymal transition through δEF1-mediated downregulation of ESRP. Oncogene 31, 3190-3201.
9. Fukagawa A, Ishii H, Miyazawa K, and, Saitoh M, (2015) δEF1 associates with DNMT1 and maintains DNA methylation of the E-cadherin promoter in breast cancer cells. Cancer Med 4, 125-135.
10. Shirakihara T, Horiguchi T, Miyazawa M, Ehata S, Shibata T, Morita I, Miyazono K, and, Saitoh M, (2011) TGF-β regulates isoform switching of FGF receptors and epithelial-mesenchymal transition. EMBO J 30, 783-795.
11. Shirakihara T, Saitoh M, and, Miyazono K, (2007) Differential regulation of epithelial and mesenchymal markers by δEF1 proteins in epithelial mesenchymal transition induced by TGF-β. Mol Biol Cell 18, 3533-3544.
12. Miyoshi N, Ishii H, Sekimoto M, Doki Y, and, Mori M, (2009) RGS16 is a marker for prognosis in colorectal cancer. Ann Surg Oncol 16, 3507-3514.
13. Saitoh M, (2015) Epithelial-mesenchymal transition is regulated at post-transcriptional levels by transforming growth factor-β signaling during tumor progression. Cancer Sci 106, 481-488.
14. Shirakihara T, Kawasaki T, Fukagawa A, Semba K, Sakai R, Miyazono K, Miyazawa K, and, Saitoh M, (2013) Identification of integrin α3 as a molecular marker of cells undergoing epithelial-mesenchymal transition and of cancer cells with aggressive phenotypes. Cancer Sci 104, 1189-1197.
15. Furlan A, Vercamer C, Bouali F, Damour I, Chotteau-Lelievre A, Wernert N, Desbiens X, and, Pourtier A, (2014) Ets-1 controls breast cancer cell balance between invasion and growth. Int J Cancer 135, 2317-2328.
16. Paumelle R, Tulasne D, Kherrouche Z, Plaza S, Leroy C, Reveneau S, Vandenbunder B, and, Fafeur V, (2002) Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway. Oncogene 21, 2309-2319.